EXTERNAL VALIDATION OF THE NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DECOMPENSATION RISK SCORE TO PREDICT HEPATIC EVENTS IN AN ETHNICALLY DIVERSE COHORT

被引:0
|
作者
Gangasani, Nikitha [1 ]
Ahmed, Heidi [2 ]
Long, Michelle [2 ]
Jayanna, Manju Bengaluru [3 ]
Sanchez, Antonio J. [4 ]
Murali, Arvind R. [5 ]
机构
[1] Boston Univ, Med Ctr, Internal Med, Boston, MA 02215 USA
[2] Boston Univ, Med Ctr, Gastroenterol, Boston, MA 02215 USA
[3] Univ Iowa, Biostat & Res Design, Inst Clin & Translat Sci, Iowa City, IA 52242 USA
[4] Univ Iowa, Sch Med, Iowa City, IA 52242 USA
[5] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1508
引用
收藏
页码:913A / 914A
页数:2
相关论文
共 50 条
  • [1] COFFEE CONSUMPTION AND GENETIC RISK SCORE IN NON-ALCOHOLIC FATTY LIVER DISEASE IN AN ETHNICALLY DIVERSE COHORT
    Chou, Alisha
    Conti, David
    Haiman, Christopher A.
    Noureddin, Mazen
    Setiawan, Veronica Wendy
    HEPATOLOGY, 2022, 76 : S857 - S858
  • [2] The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study
    Ahmed, Heidi S.
    Gangasani, Nikitha
    Jayanna, Manju B.
    Long, Michelle T.
    Sanchez, Antonio
    Murali, Arvind R.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (02) : 233 - 240
  • [3] NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED MORTALITY IN AN ETHNICALLY DIVERSE COHORT
    Chen, Hongjie
    Wilkens, Lynne
    Noureddin, Mazen
    Le Marchand, Loic
    Setiawan, Veronica Wendy
    HEPATOLOGY, 2021, 74 : 1028A - 1028A
  • [4] MENSTRUAL AND REPRODUCTIVE FACTORS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN ETHNICALLY DIVERSE WOMEN
    Wang, Jun
    Wu, Anna H.
    Porcel, Jacqueline
    Noureddin, Mazen
    Setiawan, Veronica Wendy
    HEPATOLOGY, 2019, 70 : 729A - 729A
  • [5] AGILE 3+SCORE FOR ASSESSING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) - VALIDATION IN AN INDIAN COHORT
    De, Arka
    Duseja, Ajay K.
    Mehta, Manu
    Singh, Priya
    Mehtani, Rohit
    Verma, Nipun
    Premkumar, Madhumita
    Taneja, Sunil
    Das, Ashim
    Singh, Virendra
    HEPATOLOGY, 2021, 74 : 929A - 930A
  • [6] Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
    Parameswaran, Madhangi
    Hasan, Hamzah A.
    Sadeque, Jafor
    Jhaveri, Sharan
    Avanthika, Chaithanya
    Arisoyin, Abimbola E.
    Dhanani, Maulik B.
    Rath, Swaroopa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [7] Development and validation of a risk score for detecting non-alcoholic fatty liver disease
    Jiang, Zhili
    Li, Xiang
    Yang, Duo
    Qu, Chao
    Yi, Jiayi
    Gao, Hai
    MEDICINE, 2024, 103 (46)
  • [8] Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
    Chalmers, Jane
    Ban, Lu
    Leena, Kondarapassery B.
    Edwards, Kimberley L.
    Grove, Jane L.
    Aithal, Guruprasad P.
    Shenoy, Kotacherry T.
    BMJ OPEN, 2019, 9 (05):
  • [9] Can atherosclerotic cardiovascular risk score (ASCVD) predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)?
    Golabi, P.
    Fukui, N.
    Otgonsuren, M.
    de Avila, L.
    Sayiner, M.
    Younossi, Z. M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S598 - S598
  • [10] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +